Dr. Lal PathLabs LimitedNSE: LALPATHLAB

Press Release May 17 2022

· Issued by Dr. Lal PathLabs Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

The company reported a revenue increase in the fourth quarter, with significant contributions from Covid-related services. Operating revenue rose compared to the same quarter last year, reflecting a growth trend in their diagnostics business. The press release provides a comprehensive overview of the company's financial performance and operational highlights.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Release

Dr. Lal Path Labs Ltd. has informed the Exchange about a press release dated 17-May-2022 titled Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2022.

Dr. Lal PathLabs Limited on 6ix

Earlier from Dr. Lal PathLabs

Later from Dr. Lal PathLabs

All Dr. Lal PathLabs news releases